Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2024-12-10 19:05:17
Copenhagen, Denmark, 10 December 2024 - Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) hereby announces in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, the disclosure of participation by members of Curasight's Board of Directors and Executive Management team in the warrant exercise conducted on December 5th 2024.
The following is an overview of the transactions relating to the T02 warrants:
| Name | Position | Aggregated volume | Price, DKK |
| Kirsten Drejer | Chair of the Board | 12,174 | 140,001.00 |
| Lars Trolle | Deputy chair of the Board | 5,000 | 57,500.00 |
| Charlotte Vedel Johansen | Board member | 8,695 | 99,992.50 |
| Ulrich Krasilnikoff | CEO & CFO, Board member | 43,479 | 500,008.50 |
| Andreas Kjær | CMO & CSO, Board member | 43,479 | 500,008.50 |
| Total | 112,827 | 1,297,510.50 |